The Impact of PD Check-In, a Model for Supported Self-Managed Maintenance of Speech on the Quality of Life of People with Parkinson’s Disease: A Phase 1 Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Research Design
2.2. Participants
2.3. Procedure
2.4. Outcome Measures
2.4.1. Dysarthria Impact Profile
2.4.2. PDQ-39
2.4.3. VHI
2.4.4. VHI-P
2.5. Data Analysis
3. Results
4. Discussion
5. Limitations and Future Directions
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Miller, N.; Noble, E.; Jones, D.; Burn, D. Life with communication changes in Parkinson’s disease. Age Ageing 2006, 35, 235–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yorkston, K.; Baylor, C.; Britton, D. Speech Versus Speaking: The Experiences of People with Parkinson’s Disease and Implications for Intervention. Am. J. Speech-Lang. Pathol. 2017, 26, 561–568. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dykstra, A.D.; Adams, S.G.; Jog, M. Examining the relationship between speech intensity and self-rated communicative effectiveness in individuals with Parkinson’s disease and hypophonia. J. Commun. Disord. 2015, 56, 103–112. [Google Scholar] [CrossRef] [PubMed]
- Broeders, M.; Velseboer, D.C.; de Bie, R.; Speelman, J.D.; Muslimovic, D.; Post, B.; de Haan, R.; Schmand, B. Cognitive Change in Newly-Diagnosed Patients with Parkinson’s Disease: A 5-Year Follow-up Study. J. Int. Neuropsychol. Soc. 2013, 19, 695–708. [Google Scholar] [CrossRef]
- Skodda, S.; Grönheit, W.; Mancinelli, N.; Schlegel, U. Progression of Voice and Speech Impairment in the Course of Parkinson’s Disease: A Longitudinal Study. Parkinson’s Dis. 2013, 2013, 389195. [Google Scholar] [CrossRef]
- Hartelius, L.; Svensson, P. Speech and swallowing symptoms associated with Parkinson’s disease and multiple sclerosis: A survey. Folia Phoniatr. Logop. 1994, 46, 9–17. [Google Scholar] [CrossRef]
- Logemann, J.A.; Fisher, H.B.; Boshes, B.; Blonsky, E.R. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J. Speech Hear. Disord. 1978, 43, 47–57. [Google Scholar] [CrossRef]
- Duffy, J.R. Hyokinetic dysarthria. In Motor Speech Disorders: Substrates, Differential Diagnosis, and Management, 3rd ed.; Duffy, J.R., Ed.; Elsevier Mosby: St. Louis, MO, USA, 2013; pp. 165–189. [Google Scholar]
- Altmann, L.J.P.; Troche, M.S. High-Level Language Production in Parkinson’s Disease: A Review. Parkinson’s Dis. 2011, 2011, 238956. [Google Scholar] [CrossRef] [Green Version]
- Murray, L.L.; Rutledge, S. Reading comprehension in Parkinson’s disease. Am. J. Speech-Lang. Pathol. 2014, 23, S246–S258. [Google Scholar] [CrossRef]
- Baylor, C.; Burns, M.; Eadie, T.; Britton, D.; Yorkston, K. A qualitative study of interference with communicative participation across communication disorders in adults. Am. J. Speech-Lang. Pathol. 2011, 20, 269–287. [Google Scholar] [CrossRef] [Green Version]
- Miller, N.; Andrew, S.; Noble, E.; Walshe, M. Changing perceptions of self as a communicator in Parkinson’s disease: A longitudinal follow-up study. Disabil. Rehabil. 2011, 33, 204–210. [Google Scholar] [CrossRef] [PubMed]
- Swales, M.; Theodoros, D.; Hill, A.J.; Russell, T. Communication and swallowing changes, everyday impacts and access to speech-language pathology services for people with Parkinson’s disease: An Australian survey. Int. J. Speech-Lang. Pathol. 2021, 23, 70–82. [Google Scholar] [CrossRef] [PubMed]
- Schalling, E.; Johansson, K.; Hartelius, L. Speech and Communication Changes Reported by People with Parkinson’s Disease. Folia Phoniatr. Logop. 2017, 69, 131–141. [Google Scholar] [CrossRef]
- Fleming, A.; Cook, K.F.; Nelson, N.D.; Lai, E.C. Proxy reports in Parkinson’s disease: Caregiver and patient self-reports of quality of life and physical activity. Mov. Disord. Off. J. Mov. Disord. Soc. 2005, 20, 1462–1468. [Google Scholar] [CrossRef] [PubMed]
- Miller, N.; Noble, E.; Jones, D.; Allcock, L.; Burn, D.J. How do I sound to me? Perceived changes in communication in Parkinson’s disease. Clin. Rehabil. 2008, 22, 14–22. [Google Scholar] [CrossRef] [PubMed]
- Parveen, S.; Goberman, A.M. Comparison of self and proxy ratings for voice handicap index and motor-related quality-of-life of individuals with Parkinson’s disease. Int. J. Speech-Lang. Pathol. 2017, 19, 174–183. [Google Scholar] [CrossRef]
- Levy, E.S.; Moya-Gale, G.; Chang, Y.H.M.; Freeman, K.; Forrest, K.; Brin, M.F.; Ramig, L.A. The effects of intensive speech treatment on intelligibility in Parkinson’s disease: A randomised controlled trial. EClinicalMedicine 2020, 24, 100429. [Google Scholar] [CrossRef]
- Ramig, L.; Halpern, A.; Spielman, J.; Fox, C.; Freeman, K. Speech treatment in Parkinson’s disease: Randomized controlled trial (RCT). Mov. Disord. Off. J. Mov. Disord. Soc. 2018, 33, 1777–1791. [Google Scholar] [CrossRef]
- Ramig, L.O.; Sapir, S.; Countryman, S.; Pawlas, A.A.; O’Brien, C.; Hoehn, M.; Thompson, L.L. Intensive voice treatment (LSVT) for patients with Parkinson’s disease: A 2 year follow up. J. Neurol. Neurosurg. Psychiatry 2001, 71, 493–498. [Google Scholar] [CrossRef]
- Wight, S.; Miller, N. Lee Silverman Voice Treatment for people with Parkinson’s: Audit of outcomes in a routine clinic. Int. J. Lang. Commun. Disord. 2015, 50, 215–225. [Google Scholar] [CrossRef]
- Edwards, A.; Theodoros, D.; Davidson, B. Group therapy for maintenance of speech in Parkinson’s disease following LSVT LOUD: A pilot study. Speech Lang. Hear. 2018, 21, 105–116. [Google Scholar] [CrossRef]
- Quinn, R.; Park, S.; Theodoros, D.; Hill, A.J. Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson’s disease: A pilot study. Int. J. Speech-Lang. Pathol. 2019, 21, 385–394. [Google Scholar] [CrossRef] [PubMed]
- Jacobson, B.H.; Johnson, A.; Grywalski, C.; Silbergleit, A.; Jacobson, G.; Benninger, M.S.; Newman, C.W. The Voice Handicap Index (VHI): Development and Validation. Am. J. Speech-Lang. Pathol. 1997, 6, 66–70. [Google Scholar] [CrossRef]
- Lomas, J.; Pickard, L.; Bester, S.; Elbard, H.; Finlayson, A.; Zoghaib, C. The Communicative Effectiveness Index: Development and Psychometric Evaluation of a Functional Communication Measure for Adult Aphasia. J. Speech Hear. Disord. 1989, 54, 113–124. [Google Scholar] [CrossRef] [PubMed]
- Paull, D.R.; Frattali, C.M.; Holland, A.L.; Thompson, C.K.; Caperton, C.J.; Slater, S.C. Quality of Communication Life Scale (ASHA QOL); American Speech-Language-Hearing Association: Rockville, MD, USA, 2004. [Google Scholar]
- Walshe, M.; Peach, R.K.; Miller, N. Dysarthria Impact Profile: Development of a scale to measure psychosocial effects. Int. J. Lang. Commun. Disord. 2009, 44, 693–715. [Google Scholar] [CrossRef]
- Jenkinson, C.; Fitzpatrick, R.; Peto, V.; Greenhall, R.; Hyman, N. The Parkinson’s Disease Questionnaire (PDQ-39): Development and validation of a Parkinson’s disease summary index score. Age Ageing 1997, 26, 353–357. [Google Scholar] [CrossRef] [Green Version]
- Spurgeon, L.; Clarke, C.E.; Sackley, C. Subjective Experiences of Speech and Language Therapy in Patients with Parkinson’s Disease: A Pilot Study. Rehabil. Res. Pract. 2015, 2015, 839895. [Google Scholar] [CrossRef] [Green Version]
- Finnimore, A.; Theodoros, D.; Rumbach, A.F. PD Check-In: The development and trial of a supported self-management program for people with Parkinson’s disease following intensive speech intervention. Int. J. Lang. Commun. Disord. 2022, 57, 138–151. [Google Scholar] [CrossRef]
- Robey, R.R. A five-phase model for clinical- outcome research. J. Commun. Disord. 2004, 37, 401–411. [Google Scholar] [CrossRef]
- Hoehn, M.M.; Yahr, M.D. Parkinsonism: Onset, progression and mortality. Neurology 1967, 17, 427–442. [Google Scholar] [CrossRef] [Green Version]
- Finnimore, A.; Theodoros, D.; Rumbach, A.F. Clinical outcomes of PD Check-In, a model for supported self-managed maintenance of speech in Parkinson’s Disease: A Phase 1 study. Submitted.
- Ramig, L.O.; Countryman, S.; Thompson, L.L.; Horii, Y. Comparison of two forms of intensive speech treatment for Parkinson disease. J. Speech Hear. Res. 1995, 38, 1232–1251. [Google Scholar] [CrossRef] [PubMed]
- Fox, C.; Ebersbach, G.; Ramig, L.; Sapir, S. LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease. Parkinson’s Dis. 2012, 2012, 391946. [Google Scholar] [CrossRef] [PubMed]
- Zraick, R.I.; Risner, B.Y.; Smith-Olinde, L.; Gregg, B.A.; Johnson, F.L.; McWeeny, E.K. Patient versus partner perception of voice handicap. J. Voice 2007, 21, 485–494. [Google Scholar] [CrossRef] [PubMed]
- Armstrong, R.A. When to use the Bonferroni correction. Ophthalmic Physiol. Opt. 2014, 34, 502–508. [Google Scholar] [CrossRef] [PubMed]
- McAuliffe, M.J.; Baylor, C.R.; Yorkston, K.M. Variables associated with communicative participation in Parkinson’s disease and its relationship to measures of health-related quality-of-life. Int. J. Speech-Lang. Pathol. 2017, 19, 407–417. [Google Scholar] [CrossRef]
- Berardi, A.; Regoli, E.; Tofani, M.; Valente, D.; Fabbrini, G.; Fabbrini, A.; Galeoto, G. Tools to assess the quality of life in patients with Parkinson’s disease: A systematic review. Expert Rev. Pharmacoecon. Outcomes Res. 2021, 21, 55–68. [Google Scholar] [CrossRef]
- Eadie, T.; Kapsner-Smith, M.; Bolt, S.; Sauder, C.; Yorkston, K.; Baylor, C. Relationship between perceived social support and patient-reported communication outcomes across communication disorders: A systematic review. Int. J. Lang. Commun. Disord. 2018, 53, 1059–1077. [Google Scholar] [CrossRef]
- Atkinson-Clement, C.; Letanneux, A.; Baille, G.; Cuartero, M.-C.; Véron-Delor, L.; Robieux, C.; Berthelot, M.; Robert, D.; Azulay, J.-P.; Defebvre, L.; et al. Psychosocial Impact of Dysarthria: The Patient-Reported Outcome as Part of the Clinical Management. Neurodegener. Dis. 2019, 19, 12–21. [Google Scholar] [CrossRef]
- Baylor, C.; Yorkston, K.; Eadie, T.; Kim, J.; Chung, H.; Amtmann, D. The Communicative Participation Item Bank (CPIB): Item bank calibration and development of a disorder-generic short form. J. Speech Lang. Hear. Res. 2013, 56, 1190–1208. [Google Scholar] [CrossRef]
- Liebermann, J.D.; Witte, O.W.; Prell, T. Association between different coping styles and health-related quality of life in people with Parkinson’s disease: A cross-sectional study. BMJ Open 2020, 10, e036870. [Google Scholar] [CrossRef]
- Martinez-Martin, P.; Jeukens-Visser, M.; Lyons, K.E.; Rodriguez-Blazquez, C.; Selai, C.; Siderowf, A.; Welsh, M.; Poewe, W.; Rascol, O.; Sampaio, C.; et al. Health-related quality-of-life scales in Parkinson’s disease: Critique and recommendations. Mov. Disord. 2011, 26, 2371–2380. [Google Scholar] [CrossRef] [PubMed]
- Martinez-Martin, P. What is quality of life and how do we measure it? Relevance to Parkinson’s disease and movement disorders. Mov. Disord. 2016, 32, 382–392. [Google Scholar] [CrossRef] [PubMed]
- Eadie, T.L.; Yorkston, K.M.; Klasner, E.R.; Dudgeon, B.J.; Deitz, J.C.; Baylor, C.R.; Miller, R.M.; Amtmann, D. Measuring Communicative Participation: A Review of Self-Report Instruments in Speech-Language Pathology. Am. J. Speech-Lang. Pathol. 2006, 15, 307–320. [Google Scholar] [CrossRef]
- Donovan, N.J.; Kendall, D.L.; Young, M.E.; Rosenbek, J.C. The communicative effectiveness survey: Preliminary evidence of construct validity. Am. J. Speech-Lang. Pathol. 2008, 17, 335–347. [Google Scholar] [CrossRef]
- Rosqvist, K.; Hagell, P.; Odin, P.; Ekstrom, H.; Iwarsson, S.; Nilsson, M.H. Factors associated with life satisfaction in Parkinson’s disease. Acta Neurol. Scand. 2017, 136, 64–71. [Google Scholar] [CrossRef]
Participant | Age (Years) | Gender | Time Post PD Diagnosis (Years) | Hoehn and Yahr Stage | Severity of Dysarthria | DBS | Relationship of Communication Partner |
---|---|---|---|---|---|---|---|
1 | 65 | Male | 5.0 | 2.0 | Mild | N | Spouse |
2 | 70 | Male | 10.0 | 3.0 | Mild | N | Spouse |
3 | 71 | Female | 0.8 | 2.0 | Mild | Y 18 mths post-Tx | Spouse |
4 | 70 | Male | 0.6 | 2.0 | Mild-mod | N | Spouse |
5 | 74 | Male | 5.0 | 3.0 | Mild | N | Spouse |
6 | 75 | Female | 2.0 | 3.0 | Mild | N | Spouse |
7 | 70 | Female | 3.0 | 3.0 | Mild | N | Daughter-in-law |
8 | 77 | Male | 3.0 | 1.0 | Mild | N | Spouse |
9 | 61 | Male | 11.0 | 1.0 | Mild | N | Spouse |
10 | 82 | Female | 8.0 | 1.0 | Mild | N | Spouse * |
11 | 79 | Male | 6.0 | 4.0 | Mild | N | Spouse |
12 | 81 | Male | 7.0 | 3.0 | Mild | N | Spouse |
13 | 73 | Female | 5.0 | 2.0 | Mild | N | Spouse |
14 | 62 | Male | 18.0 | 3.0 | Severe | Y 6 years pre-Tx | Spouse |
15 | 74 | Female | 9.0 | 2.0 | Mild-mod | N | Daughter |
16 | 48 | Female | 1.0 | 3.0 | Moderate | N | Spouse |
Treatment | Maintenance | |||||||
---|---|---|---|---|---|---|---|---|
Pre-LSVT-LOUD | Post-LSVT-LOUD | 6 Weeks | 12 Weeks | 6 Months | 12 Months | 24 Months | ||
PWPD | DIP | X | X | X | X | |||
PDQ-39 | X All | X Comm | X Comm | X Comm | X Comm | X All | ||
VHI | X | X | X | X | ||||
CP | VHI-P | X | X | X | X |
Pre Median (IQR) | Post Median (IQR) | Z | p * | Post Median (IQR) | 12 m Median (IQR) | Z | p * | Post Median (IQR) | 24 m Median (IQR) | Z | p * | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
DIP | ||||||||||||
A. | 39.00 | 40.50 | −1.924 | 0.054 | 40.50 | 39.00 | −1.665 | 0.096 | 40.50 | 38.50 | −1.892 | 0.058 |
(12.00) | (9.75) | (12.00) | (7.75) | (7.75) | (12.00) | |||||||
B. | 32.00 | 34.50 | −1.147 | 0.251 | 34.50 | 32.00 | −0.570 | 0.568 | 34.50 | 33.00 | −1.038 | 0.299 |
(4.50) | (10.50) | (10.50) | (6.50) | (10.50) | (6.50) | |||||||
C. | 44.50 | 46.50 | −1.340 | 0.180 | 46.50 | 45.00 | −0.692 | 0.489 | 46.50 | 46.50 | −0.171 | 0.864 |
(8.00) | (6.25) | (11.25) | (8.00) | (8.00) | (8.00) | |||||||
D. | 38.50 | 41.00 | −1.110 | 0.267 | 41.00 | 41.00 | −0.288 | 0.820 | 41.00 | 41.00 | −0.127 | 0.899 |
(8.00) | (10.00) | (8.25) | (8.00) | (8.00) | (7.25) | |||||||
E. | 2.50 | 3.00 | −0.998 | 0.318 | 3.00 | 4.00 | −1.392 | 0.164 | 3.00 | 4.00 | −2.271 | 0.023 |
(2.75) | (1.00) | (2.75) | (2.75) | (2.75) | (2.75) | |||||||
Total | 153.50 | 165.0 | −2.558 | 0.011 | 165.00 | 159.50 | −0.540 | 0.589 | 165.00 | 161.00 | −0.884 | 0.377 |
(33.00) | (19.75) | (33.00) | (20.00) | (34.25) | (33.00) | |||||||
VHI | ||||||||||||
P | 21.50 | 16.00 | −1.734 | 0.083 | 16.00 | 16.00 | −0.835 | 0.404 | 16.00 | 17.00 | −1.383 | 0.167 |
(9.25) | (8.00) | (9.25) | (7.50) | (19.75) | (9.25) | |||||||
F | 16.50 | 10.50 | −0.598 | 0.550 | 10.50 | 11.50 | −1.663 | 0.096 | 10.50 | 14.00 | −2.181 | 0.029 |
(9.75) | (9.75) | (9.75) | (8.75) | (14.5) | (9.75) | |||||||
E | 13.50 | 7.50 | −1.039 | 0.299 | 7.50 | 9.50 | −1.170 | 0.242 | 7.50 | 10.50 | −0.906 | 0.365 |
(15.25) | (13.00) | (13.00) | (10.75) | (13.00) | (13.25) | |||||||
Total | 53.50 | 35.50 | −1.475 | 0.140 | 35.50 | 37.00 | −1.061 | 0.289 | 35.50 | 42.00 | −1.591 | 0.112 |
(31.00) | (25.00) | (31.00) | (28.50) | (46.00) | (31.00) | |||||||
VHI-P | ||||||||||||
P | 20.00 | 17.00 | −0.525 | 0.599 | 17.00 | 18.00 | −0.317 | 0.751 | 17.00 | 17.00 | −0.629 | 0.529 |
(6.00) | (10.00) | (6.00) | (9.00) | (9.00) | (6.00) | |||||||
F | 21.00 | 15.00 | −1.849 | 0.064 | 15.00 | 18.00 | −1.652 | 0.099 | 15.00 | 18.00 | −1.262 | 0.207 |
(9.00) | (10.00) | (9.00) | (10.00) | (20.00) | (9.00) | |||||||
E | 19.00 | 15.00 | −2.029 | 0.043 | 15.00 | 12.00 | −0.824 | 0.400 | 15.00 | 14.00 | −1.056 | 0.291 |
(5.00) | (7.00) | (5.00) | (12.00) | (21.00) | (5.00) | |||||||
Total | 58.00 | 46.00 | −1.819 | 0.069 | 46.00 | 51.00 | −0.856 | 0.392 | 46.00 | 48.00 | −0.398 | 0.691 |
(25.00) | (27.00) | (25.00) | (30.00) | (45.00) | (25.00) |
VHI Median; (IQR) | VHI-P Median; (IQR) | Z | p | |
---|---|---|---|---|
P1 | 21.50; (19.75) | 20.00; (9.00) | −0.752 | 0.470 |
P2 | 16.00; (9.25) | 17.00; (6.00) | −0.357 | 0.740 |
P3 | 16.00; (8.00) | 18.00; (10.00) | −0.418 | 0.682 |
P4 | 17.00; (7.50) | 17.00; (9.00) | −0.635 | 0.545 |
F1 | 16.50; (14.50) | 21.00; (20.00) | −1.050 | 0.299 |
F2 | 10.50; (9.75) | 15.00; (9.00) | −1.486 | 0.140 |
F3 | 11.50; (9.75) | 18.00; (10.00) | −1.446 | 0.151 |
F4 | 14.00; (8.75) | 18.00; (10.00) | −0.674 | 0.520 |
E1 | 13.50; (15.25) | 19.00; (21.00) | −1.108 | 0.281 |
E2 | 7.50; (13.00) | 15.00; (5.00) | −1.230 | 0.232 |
E3 | 9.50; (13.25) | 12.00; (7.00) | −0.495 | 0.626 |
E4 | 10.50; (10.75) | 14.00; (12.00) | −0.832 | 0.423 |
T1 | 53.50; (46.00) | 58.00; (45.00) | −0.534 | 0.599 |
T2 | 35.50; (31.00) | 46.00; (25.00) | −1.029 | 0.318 |
T3 | 37.00; (25.00) | 51.00; (27.00) | −0.870 | 0.401 |
T4 | 42.00; (28.50) | 48.00; (30.00) | −2.97 | 0.770 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Finnimore, A.; Theodoros, D.; Rumbach, A. The Impact of PD Check-In, a Model for Supported Self-Managed Maintenance of Speech on the Quality of Life of People with Parkinson’s Disease: A Phase 1 Study. Brain Sci. 2022, 12, 433. https://doi.org/10.3390/brainsci12040433
Finnimore A, Theodoros D, Rumbach A. The Impact of PD Check-In, a Model for Supported Self-Managed Maintenance of Speech on the Quality of Life of People with Parkinson’s Disease: A Phase 1 Study. Brain Sciences. 2022; 12(4):433. https://doi.org/10.3390/brainsci12040433
Chicago/Turabian StyleFinnimore, Ann, Deborah Theodoros, and Anna Rumbach. 2022. "The Impact of PD Check-In, a Model for Supported Self-Managed Maintenance of Speech on the Quality of Life of People with Parkinson’s Disease: A Phase 1 Study" Brain Sciences 12, no. 4: 433. https://doi.org/10.3390/brainsci12040433
APA StyleFinnimore, A., Theodoros, D., & Rumbach, A. (2022). The Impact of PD Check-In, a Model for Supported Self-Managed Maintenance of Speech on the Quality of Life of People with Parkinson’s Disease: A Phase 1 Study. Brain Sciences, 12(4), 433. https://doi.org/10.3390/brainsci12040433